Quantitative Investment Management LLC increased its stake in shares of Vitamin Shoppe, Inc (NYSE:VSI) by 69.0% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 67,600 shares of the specialty retailer’s stock after buying an additional 27,600 shares during the quarter. Quantitative Investment Management LLC owned about 0.29% of Vitamin Shoppe worth $787,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in VSI. Arizona State Retirement System boosted its stake in Vitamin Shoppe by 0.8% during the first quarter. Arizona State Retirement System now owns 12,360 shares of the specialty retailer’s stock worth $249,000 after buying an additional 100 shares during the last quarter. Texas Permanent School Fund grew its holdings in Vitamin Shoppe by 0.8% in the 2nd quarter. Texas Permanent School Fund now owns 17,389 shares of the specialty retailer’s stock valued at $203,000 after buying an additional 145 shares in the last quarter. BNP Paribas Arbitrage SA grew its holdings in Vitamin Shoppe by 2.1% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after buying an additional 192 shares in the last quarter. Mason Street Advisors LLC grew its holdings in Vitamin Shoppe by 7.0% in the 1st quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock valued at $112,000 after buying an additional 366 shares in the last quarter. Finally, Capstone Asset Management Co. grew its holdings in Vitamin Shoppe by 3.5% in the 2nd quarter. Capstone Asset Management Co. now owns 14,040 shares of the specialty retailer’s stock valued at $164,000 after buying an additional 470 shares in the last quarter. Hedge funds and other institutional investors own 96.86% of the company’s stock.

Vitamin Shoppe, Inc (VSI) opened at 5.35 on Monday. The stock has a 50 day moving average price of $6.38 and a 200 day moving average price of $12.76. Vitamin Shoppe, Inc has a 52 week low of $4.95 and a 52 week high of $28.41. The firm’s market cap is $124.24 million.

Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.39 by ($0.16). The business had revenue of $304.84 million during the quarter, compared to analyst estimates of $314.74 million. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. The company’s revenue was down 8.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.55 earnings per share. Equities research analysts expect that Vitamin Shoppe, Inc will post $0.79 EPS for the current year.

Several research analysts have recently commented on the company. Goldman Sachs Group, Inc. (The) reiterated a “sell” rating and set a $6.00 price target (down previously from $13.00) on shares of Vitamin Shoppe in a report on Thursday, August 10th. Deutsche Bank AG reissued a “hold” rating and issued a $7.00 price objective (down previously from $14.00) on shares of Vitamin Shoppe in a report on Thursday, August 10th. Barclays PLC dropped their price objective on shares of Vitamin Shoppe from $13.00 to $6.00 and set an “equal weight” rating for the company in a report on Thursday, August 10th. TheStreet lowered shares of Vitamin Shoppe from a “c-” rating to a “d” rating in a report on Wednesday, August 9th. Finally, Morgan Stanley set a $8.00 price objective on shares of Vitamin Shoppe and gave the stock a “hold” rating in a research report on Thursday, August 10th. Four research analysts have rated the stock with a sell rating and six have given a hold rating to the company. Vitamin Shoppe presently has a consensus rating of “Hold” and an average price target of $12.43.

WARNING: This report was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another website, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/10/02/quantitative-investment-management-llc-has-787000-position-in-vitamin-shoppe-inc-vsi.html.

In other Vitamin Shoppe news, Director John D. Bowlin acquired 40,000 shares of the firm’s stock in a transaction dated Friday, August 25th. The shares were acquired at an average price of $5.50 per share, for a total transaction of $220,000.00. Following the completion of the acquisition, the director now directly owns 56,028 shares of the company’s stock, valued at $308,154. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.07% of the stock is owned by company insiders.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Stock Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related stocks with our FREE daily email newsletter.